Metronomic Adjuvant Chemotherapy Improves Treatment Outcome in Nasopharyngeal Carcinoma Patients with Post-radiation Persistently Detectable Plasma EBV DNA
Chih-Wen Twu, Wen-Yi Wang, Chien-Chih Chen, Kai-Li Liang, Rong-San Jiang, Ching-Te Wu, Yi-Ting Shih, Po-Ju Lin, Yi-Chun Liu, Jin-Ching Lin
Index: Int. J. Radiat. Oncol. Biol. Phys. 89(1) , 21-9, (2014)
Full Text: HTML
Abstract
Purpose To investigate the effects of adjuvant chemotherapy in nasopharyngeal carcinoma (NPC) patients with persistently detectable plasma Epstein-Barr virus DNA (pEBV DNA) after curative radiotherapy plus induction/concurrent chemotherapy.
Related Compounds
Related Articles:
2014-01-01
[Springerplus 3 , 417, (2014)]
2010-01-01
[Chem. Res. Toxicol. 23 , 171-83, (2010)]
2008-03-01
[Eur. J. Med. Chem. 43 , 478-85, (2008)]
2008-11-13
[J. Med. Chem. 51 , 6740-51, (2008)]
2015-12-01
[Environ. Sci. Pollut. Res. Int. 22 , 18676-86, (2015)]